Relationship of Testicular Volume, Follicle-stimulating Hormone (FSH) and Azoospermia Factor (AZF) Gene Microdeletion in Patients with Non-obstructive Azoospermia (NOA) and Cryptozoospermia
Ju-fen ZHENG,Chang-gen SHI,Xiao-bao CHEN,Lei-wen ZHAO,Zu-qiong XIANG,Yan ZHANG,Yan-cheng WU,Yuan-chun LI
DOI: https://doi.org/10.7669/j.issn.0253-357X.2013.12.0811
2013-01-01
Abstract:Objective: To explore the relationship of testicular volume, follicle-stimulating hormone(FSH) and azoospermia factor(AZF) deletion gene microdeletion in patients with non-obstructive azoospermia(NOA) and cryptozoospermia. Methods: Totally 161 male infertility patients were drawn, and testicular volumes, FSH level and AZF microdeletion were recorded. The examination of AZF microdeletion includes AZFa(sY84, sY86), AZFb(sY127, sY134), AZFc(sY254, sY255, sY157), AZFd(sY145, sY152). All patients were divided into four groups. Group A: 86 patients were NOA; group B: 49 patients were cryptozoospermia; group C: 13 patients were severe oligozoospermia patients; group D: 13 cases were enrolled, including 4 necrospermia patients, 3 obstructive azoospermia patients, 1 normal sperm patient and 5 oligoasthenozoospermia patients. Results: The proportions of the testicular volume less than 12 ml were 73.26%(63/86) in group A, 34.69%(17/49) in group B, 7.69%(1/13) in group C, 30.77%(4/13) in group D with significant differences(P<0.001); the proportions of increasing FSH level with value increased more than 1 fold in 4 groups were 67.44%(58/86), 32.65%(16/49), 15.38%(2/13) and 0.00%(0/13), respectively, with significant differences(P<0.001); the AZF gene microdeletion of four groups were 15.12%(13/86), 18.37%(9/49), 0.00%(0/13) and 0.00%(0/13), respectively(P>0.05). In group A, one patient was AZFa gene microdeletion, 5 were AZF(b+c+d) gene microdeletion, 7 were AZF(c+d) gene microdeletion and in group B, 9 patients were AZFc and/or AZFd gene microdeletion. Conclusion: With development of spermatogenesis dysfunction, there was a significant higher level of FSH and lower volume of testes, additionally, no difference was found when comparing the incidence of AZF gene microdeletion. However, incidence of AZF gene microdeletion was still high in patients with NOA or cryptozoospermia. Moreover, AZFa and AZFb gene microdeletion were common in patients with NOA, while AZFc and AZFd gene microdeletion were common in cryptozoospermia.